COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,832 Articles (22,553 medRxiv, 8,279 bioRxiv)

Most recent first Previous |  Page 2928: Articles 29271-29280  | Next

Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions
Farkas, C., Fuentes-Villalobos, F., Garrido, J. L., Haigh, J. J., Barria, M. I.
10.1101/2020.04.09.034462 — Posted: 2020-04-12 Discussion: Onsite | Offsite
BIP4COVID19: Releasing impact metrics data for articles relevant to COVID-19
Vergoulis, T., Kanellos, I., Chatzopoulos, S., Pla Karidi, D., Dalamagas, T.
10.1101/2020.04.11.037093 — Posted: 2020-04-12
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
Liu, H., Ye, F., Sun, Q., Liang, H., Li, C., Lu, R., Huang, B., Tan, W., Lai, L.
10.1101/2020.04.10.035824 — Posted: 2020-04-12 Discussion: Onsite | Offsite
Comparison of SARS-CoV-2 infections among 3 species of non-human primates
Lu, S., Zhao, Y., Yu, W., Yang, Y., Gao, J., Wang, J., Kuang, D., Yang, M., Yang, J., Ma, C., Xu, J., Li, H., Zhao, S., Li, J., Wang, H., Long, H., Zhou, J., Luo, F., Ding, K., Wu, D., Zhang, Y., Dong, Y., Liu, Y., Zheng, Y., Lin, X., Jiao, L., Zheng, H., Dai, Q., Sun, Q., Hu, Y., Ke, C., Liu, H., Peng, X.
10.1101/2020.04.08.031807 — Posted: 2020-04-12 Discussion: Onsite | Offsite
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
Quinlan, B. D., Mou, H., Zhang, L., Gao, Y., He, W., Ojha, A., Parcells, M. S., Luo, G., Li, W., Zhong, G., Choe, H., Farzan, M.
10.1101/2020.04.10.036418 — Posted: 2020-04-12 Discussion: Onsite
Analysis of Ten Microsecond simulation data of SARS-CoV-2 dimeric main protease
Parves, R., Riza, Y., Mahmud, S., Islam, R., Ahmed, S., Evy, B. A., Hasan, H., Halim, M. A.
10.1101/2020.04.10.036020 — Posted: 2020-04-12
Structural interactions between pandemic SARS-CoV-2 spike glycoprotein and human Furin protease
Vankadari, N.
10.1101/2020.04.10.036533 — Posted: 2020-04-12 Discussion: Onsite
Age-stratified Infection Probabilities Combined with Quarantine-Modified SEIR Model in the Needs Assessments for COVID-19
Bongolan, V. P., Minoza, J. M. A., de Castro, R., Sevilleja, J. E.
10.1101/2020.04.08.20057851 — Posted: 2020-04-11
Fear of exponential growth in Covid19 data of India andfuture sketching
Mondal, S., Ghosh, S.
10.1101/2020.04.09.20058933 — Posted: 2020-04-11
Nitric oxide gas inhalation to prevent COVID-2019 in healthcare providers
Gianni, S., Safaee Fakhr, B., Morais, C. C. A., Di Fenza, R., Larson, G., Pinciroli, R., Houle, T., Mueller, A. L., Bellavia, A., Kacmarek, R., Carroll, R., Berra, L.
10.1101/2020.04.05.20054544 — Posted: 2020-04-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).